These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 798586

  • 1. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Schnitker J, Brock N, Burkert H, Fichtner E.
    Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586
    [Abstract] [Full Text] [Related]

  • 2. Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.
    Brühl P, Günther U, Hoefer-Janker H, Hüls W, Scheef W, Vahlensieck W.
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):29-39. PubMed ID: 789266
    [Abstract] [Full Text] [Related]

  • 3. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [Abstract] [Full Text] [Related]

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G, Neidhardt B, Lutz H.
    Med Klin; 1978 Sep 08; 73(36):1247-52. PubMed ID: 692477
    [Abstract] [Full Text] [Related]

  • 7. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I, Kazuta M, Miyao J, Kunimi N, Kawamoto M, Tanimura T, Fujiwara K, Sekiba K.
    Gan To Kagaku Ryoho; 1983 May 08; 10(5):1278-84. PubMed ID: 6870299
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M, Tsunawaki A, Nishida T, Nishimura H, Natsuaki Y, Inoue T, Kato T.
    Acta Obstet Gynaecol Jpn; 1981 Jul 08; 33(7):1071-6. PubMed ID: 7304132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    König HJ, Hartwich G.
    Dtsch Med Wochenschr; 1980 Dec 26; 105(52):1810-4. PubMed ID: 7449648
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B, Hansen OP, Hansen HH, Hansen M.
    Semin Oncol; 1992 Feb 26; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY, Boros L, Garrow GC, Asbury RF, Hui L.
    Semin Oncol; 1996 Jun 26; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT.
    Semin Oncol; 1997 Aug 26; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.